“…According to bacteriological data in the literature, authors have shown that most cases of pyoderma are caused by S. pyogenes in several tropical developing settings, 1,2,9–12 and therefore narrow‐spectrum penicillins might be the most appropriate candidates for standard treatment. Mass or selective treatment with intramuscular benzathine‐penicillin has been recommended during epidemics of poststreptococcal glomerulonephritis, 9,13 but, apart from this specific situation, very few therapeutic trials for pyoderma in a tropical environment are available; furthermore, published studies have largely focused on potential second‐line drugs such as cotrimoxazole or flucloxacillin, 14,15 or costly drugs that are seldom available in developing countries such as topical mupirocin or fusidic acid 16,17 ; in addition, none of those trials has been comparative.…”